Sai Life Sciences Ltd
Company Profile
Business description
Sai Life Sciences Ltd is an innovator-focused, contract research, development, and manufacturing organization. It provides end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities (NCE), to pharmaceutical innovator companies and biotechnology firms. It possesses both; discovery/contract research (CRO) and chemistry, manufacturing, and control (CMC)/contract development and manufacturing organization (CDMO) capabilities. The company has only one reportable segment: contract research, development, and manufacturing. Geographically it operates in India as well as Outside India.
Contact
Gachibowli Miyapur Road
L4- 01 & 02, SLN Terminus Survey, Survey no. 133
Gachibowli
HyderabadTG500032
INDT: +91 4068156000
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 March 2026
Employees
3,401
Stocks News & Analysis
stocks
Going into earnings, is Netflix stock a buy, a sell, or fairly valued?
stocks
Bapcor is paying for the sins of its past
stocks
Overvalued ASX share as market underestimates downside risks
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,384.90 | 11.20 | 0.12% |
CAC 40 | 8,206.07 | 31.87 | 0.39% |
DAX 40 | 24,258.80 | 427.81 | 1.80% |
Dow JONES (US) | 46,706.58 | 515.97 | 1.12% |
FTSE 100 | 9,403.57 | 49.00 | 0.52% |
HKSE | 26,286.47 | 427.64 | 1.65% |
NASDAQ | 22,990.54 | 310.57 | 1.37% |
Nikkei 225 | 49,585.50 | 400.00 | 0.81% |
NZX 50 Index | 13,377.85 | 32.89 | 0.25% |
S&P 500 | 6,735.13 | 71.12 | 1.07% |
S&P/ASX 200 | 9,091.40 | 15.50 | 0.17% |
SSE Composite Index | 3,910.13 | 46.24 | 1.20% |